The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 05, 2022
Filed:
Jun. 14, 2018
Applicant:
Zander Therapeutics, Inc., La Mesa, CA (US);
Inventors:
Harry M. Lander, La Mesa, CA (US);
David R. Koos, La Mesa, CA (US);
Assignee:
Zander Biologics, Inc, La Mesa, CA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/381 (2006.01); A61K 31/4025 (2006.01); A61K 31/4436 (2006.01); C07D 409/14 (2006.01); C07D 409/04 (2006.01); C07D 333/48 (2006.01); A61K 35/17 (2015.01); A61K 31/366 (2006.01); A61K 31/4245 (2006.01); A61K 31/4706 (2006.01); A61K 31/496 (2006.01); A61K 31/506 (2006.01); A61K 31/5377 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
C07D 409/14 (2013.01); A61K 31/366 (2013.01); A61K 31/381 (2013.01); A61K 31/4025 (2013.01); A61K 31/4245 (2013.01); A61K 31/4436 (2013.01); A61K 31/4706 (2013.01); A61K 31/496 (2013.01); A61K 31/506 (2013.01); A61K 31/5377 (2013.01); A61K 35/17 (2013.01); A61P 35/00 (2018.01); C07D 333/48 (2013.01); C07D 409/04 (2013.01);
Abstract
The present technology is directed to modulators of nuclear receptor activity, specifically to the modulation of NR2F6 activity and NR2F6 utilizing compounds, and the immune modulation and modulation of cancer stem cell activity through administration of compounds described herein.